Send to

Choose Destination
J Clin Pathol. 2015 Aug;68(8):585-91. doi: 10.1136/jclinpath-2015-203016. Epub 2015 Apr 30.

UK guidance for the pathological reporting of serrated lesions of the colorectum.

Author information

Department of Cellular Pathology, Southampton General Hospital, Southampton, UK.
Gloucestershire Cellular Pathology Laboratory, Cheltenham General Hospital, Cheltenham, UK.


Bowel cancer screening programmes have highlighted to endoscopists and clinicians the spectrum of serrated colorectal lesions. One of the most significant developments has been the recognition that sessile serrated lesions (SSLs), while bearing histological resemblance to hyperplastic polyps (HPs), may be associated with the enhanced development of epithelial dysplasia and colorectal adenocarcinoma. Different minimum criteria exist for the diagnosis of SSLs and their differentiation from HPs. Furthermore, the spectrum of terminology used to describe the entire range of serrated lesions is wide. This variability has impaired interobserver agreement during their histopathological assessment. Here, we provide guidance for the histopathological reporting of serrated lesions, including a simplified nomenclature system. Essentially, we recommend use of the following terms: HP, SSL, SSL with dysplasia, traditional serrated adenoma (TSA) and mixed polyp. It is hoped that this standardisation of nomenclature will facilitate studies of the biological significance of serrated lesions in terms of the relative risk of disease progression.


COLON; COLORECTAL CANCER; RECTUM; diagnostic screening

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center